The Dublin-headquartered pharmaceutical services company said the expanded facility would allow it to capitalise on its growing order book
Hvivo, the Dublin-listed pharmaceutical services company founded by businessman Cathal Friel, has announced plans to move to a new, expanded facility at Canary Wharf in London.
The company, which specialises in running human challenge trials for new drugs to combat infectious and respiratory diseases, said it will move to a new 50-bed state of the art facility, which will include quarantine bedrooms, advanced laboratories, an outpatient unit and corporate offices spread across two floors.
hVIVO plc (formerly Open Orphan plc) is a rapidly growing specialist contract research organisation (CRO) and the world leader in testing infectious and respiratory disease vaccines and antivirals using human challenge clinical trials, providing end-to-end early clinical development services for its broad and long-standing client base of biopharma companies.